Latest filing published 30 May 2018 for ENDOLOGIX INC /DE/.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
John D. McDermott: trading record in brief
This profile gathers the share dealings of John D. McDermott in Endologix Inc /DE/. We count 80 filings; the first trade dates from 12 May 2008 and the latest from 29 May 2018.
In open-market terms, that means 13 purchases worth €599k on one side and 30 sales worth €3.2M on the other. Sales outweigh purchases by €2.6M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 32 share grants and 3 option exercises.
Half of the purchases are above €16k and half below. Clusters matter here: 8 out of 8 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
The latest filing, published on 30 May 2018, reports a share grant of €36k in Endologix Inc /DE/. The last purchase on record was published on 30 May 2017, which is 3,449 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to John D. McDermott
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 48,222 shares0Common StockSEC:0001013606-18-000082:0
- 7,286 shares@ US$5.651.8% of flowCommon StockSEC:0001013606-18-000082:1
- 177,065 shares@ US$2.6719.6% of flowCommon StockSEC:0001013606-18-000075:0
- 133,503 shares@ US$4.7326.1% of flowCommon StockSEC:0001013606-18-000075:1
- 250,000 shares@ US$2.6726.5% of flowCommon StockSEC:0001013606-18-000033:0
- 140,000 shares0Common StockSEC:0001013606-18-000031:0
- 106,242 shares0Common StockSEC:0001013606-18-000013:0
- 14,467 shares@ US$4.052.3% of flowCommon StockSEC:0001013606-18-000013:1
- 48,222 shares0Common StockSEC:0001013606-17-000112:0
- 5,821 shares@ US$4.791.2% of flowCommon StockSEC:0001013606-17-000099:1
- 140,000 shares0Common StockSEC:0001013606-17-000098:0
- 48,222 shares0Common StockSEC:0001013606-17-000099:0
- 25,000 shares@ US$4.454.9% of flowCommon StockSEC:0001013606-17-000067:0Canonical exit: 17 Aug 2017 (T+90)
- 17,276 shares@ US$6.945.5% of flowCommon StockSEC:0001013606-17-000018:1
- 106,242 shares0Common StockSEC:0001013606-17-000018:0
- 20,588 shares@ US$5.715.5% of flowCommon StockSEC:0001013606-17-000011:1
- 108,538 shares0Common StockSEC:0001013606-17-000011:0
- 100 shares@ US$6.630.0% of flowCommon StockSEC:0001013606-16-000334:0Canonical exit: 14 Mar 2017 (T+90)
- 1,600 shares@ US$6.640.5% of flowCommon StockSEC:0001013606-16-000334:1Canonical exit: 14 Mar 2017 (T+90)
- 2,500 shares@ US$6.650.8% of flowCommon StockSEC:0001013606-16-000334:2Canonical exit: 14 Mar 2017 (T+90)
- 400 shares@ US$6.660.1% of flowCommon StockSEC:0001013606-16-000334:3Canonical exit: 14 Mar 2017 (T+90)
- 1,800 shares@ US$6.670.6% of flowCommon StockSEC:0001013606-16-000334:4Canonical exit: 14 Mar 2017 (T+90)
- 2,600 shares@ US$6.680.8% of flowCommon StockSEC:0001013606-16-000334:5Canonical exit: 14 Mar 2017 (T+90)
- 1,000 shares@ US$6.760.3% of flowCommon StockSEC:0001013606-16-000334:6Canonical exit: 14 Mar 2017 (T+90)
- 48,222 shares0Common StockSEC:0001013606-16-000264:0
25 of 71 declarations
